Literature DB >> 21362795

Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy.

Robert G Lahita, Melchiore A Vernace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21362795     DOI： 10.3899/jrheum.100968

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.

Authors:  K C Webb; R Tung; L S Winterfield; A B Gottlieb; J M Eby; S W Henning; I C Le Poole
Journal:  Br J Dermatol       Date:  2015-08-25       Impact factor: 9.302

Review 2.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

3.  Segmental vitiligo after infliximab use for rheumatoid arthritis--a case report.

Authors:  Clarissa Luiza Dalla Bernardina Carvalho; Luciena Cegatto Martins Ortigosa
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.